- Alto Neuroscience’s schizophrenia treatment granted FDA Fast Track designation
- FairJourney Biologics appoints Dr Werner Lanthaler as CEO
- ANGLE unveils new strategy with executive reshuffle and name change to CelLBx Health
- Symeres appoints Gabriella Gentile as chief operating officer
- Uterine fibroids and the cost of silence
- Owen Mumford appoints Mark Glass as pharmaceutical services director
- Recipharm designates Germany site as Centre of Excellence
- COVID-19 vaccine eligibility creates challenges for UK pharmacies
- Celtic Renewables pushes for use of bio-based materials in pharma industry
- Esaote presents new MRI system to support brain glioma surgeries
- Bio-Rad signs exclusive European distribution deal with Gencurix for oncology testing kits
- Novel excipients: the key to unlocking drug innovation
- The Pharma Files: With Colin Williams from Astellas Pharma
- How can optichannel engagement drive return on investment across the product life cycle?
- Chronic spontaneous urticaria – the impact on patient quality of life, ongoing developments in treatments and the importance of greater awareness